抗磷脂抗体患者中血小板计数对血栓风险的 stratified 分层:一项纵向研究
该单中心回顾性纵向研究纳入 953 例疑似自身免疫病患者,分析血小板计数与抗磷脂评分(aPL-S)对血栓事件的预测价值。aPL 阳性且血小板低者血栓风险更高(HR 2.95,95%CI 1.11-7.88);低 aPL-S 亚组中血小板低者风险也更高(HR 3.44,95%CI 1.05-11.2),高 aPL-S 者无论血小板计数均高血栓风险。
要点
- aPL 阳性患者中,血小板低者血栓发生率高于血小板正常者(HR 2.95,95%CI 1.11-7.88)。
- 低 aPL-S 患者中,血小板低者血栓风险更高(HR 3.44,95%CI 1.05-11.2)。
- 高 aPL-S 患者无论血小板计数如何均高血栓风险。
核心结论
- aPL 阳性且血小板低的患者血栓风险高,低 aPL-S 携带者可通过血小板计数进行风险分层。
研究设计与样本
- 单中心、回顾性、纵向研究,纳入 2002 年 1 月至 2006 年 12 月疑似自身免疫病患者 953 例。
主要发现
- aPL-S 与血小板计数呈负相关(r = -0.2477)。
- aPL 阳性患者中,血小板低者血栓发生率高于血小板正常者(HR 2.95,95%CI 1.11-7.88)。
- aPL 阴性患者中,血小板计数对血栓预测价值无差异。
- 低 aPL-S 患者中,血小板低者血栓发生率高于血小板正常者(HR 3.44,95%CI 1.05-11.2)。
- 高 aPL-S 患者无论血小板计数如何均频繁发生血栓。
关键数值与推荐
- 低血小板计数定义为 aPL 检测时血小板计数 < 150 × 10^3 μL^-1。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Essentials Thrombotic risk stratification is an unmet need in antiphospholipid antibody carriers. Platelet count and antiphospholipid score (aPL-S) were combined to predict thrombotic events. Patients with high aPL-S are at high thrombotic risk regardless of platelet count. If platelet count is low, patients with low aPL-S are also on high thrombotic risk. SUMMARY: Background Thrombocytopenia is a non-criteria clinical manifestation of antiphospholipid syndrome. However, it remains to be elucidated whether thrombocytopenia increases thrombotic risk in antiphospholipid antibody (aPL) carriers. Objectives To investigate the impact of platelet count in terms of predicting thrombotic events in aPL carriers, and to stratify the thrombotic risk by combining platelet count and antiphospholipid score (aPL-S), which represents a quantification of aPL varieties and titers. Patients/methods A single-center, retrospective, longitudinal study comprising 953 consecutive patients who were suspected of having autoimmune disease between January 2002 and December 2006 was performed. Low platelet count was defined as a count of < 150 × 103 μL-1 at the time of aPL testing. Results A negative correlation was observed between aPL-S and platelet count (r = - 0.2477). Among aPL-positive patients, those with a low platelet count developed thrombosis more frequently than those without (hazard ratio [HR] 2.95, 95% confidence interval [CI] 1.11-7.88). Among aPL-negative patients, no difference was found in the predictive value of thrombosis regardless of platelet count. Patients with aPLs were further divided into two subgroups according to aPL-S. Among low-aPL-S patients, those with low platelet counts developed thrombosis more frequently than those without (HR 3.44, 95% CI 1.05-11.2). In contrast, high-aPL-S patients developed thrombosis frequently regardless of platelet count. Conclusions aPL carriers with low platelet counts are at high risk of developing thrombosis. In particular, 'low-aPL-S carriers' may be stratified by platelet count in terms of predicting future thrombotic events.
引用
- Hisada R, Kato M, Sugawara E, et al. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study. J Thromb Haemost. 2017. PMID: 28662299. doi:10.1111/jth.13763
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。